AZ scores first 2022 PBS listing

AstraZeneca is first out of the gate for 2022, announcing Forxiga will be listed on the PBS from New Years Day providing Australians living with heart failure broader access to another treatment option that may help to reduce the number of hospitalisations and cardiovascular deaths.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here